Baolingbao Biology Co Ltd (002286) — Financial Flexibility Index
Baolingbao Biology Co Ltd (002286) has a Financial Flexibility Index of 0.33x as of September 2025. Free cash flow of CN¥177.26 Million (operating CF CN¥134.96 Million minus capex CN¥42.30 Million) represents 0% of total liabilities (CN¥532.41 Million). Also explore Baolingbao Biology Co Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Baolingbao Biology Co Ltd Financial Flexibility Index (2006–2024)
Historical Financial Flexibility Index trend for Baolingbao Biology Co Ltd across 19 annual periods. Check how strategically is Baolingbao Biology Co Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Baolingbao Biology Co Ltd (2006–2024)
Year-by-year free cash flow to debt coverage for Baolingbao Biology Co Ltd. For the full company profile including market capitalisation, see 002286 market cap overview.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.69x | CN¥438.65 Million | CN¥248.72 Million | CN¥632.44 Million | ▲ +7.8% |
| 2023 | 0.64x | CN¥434.51 Million | CN¥282.28 Million | CN¥675.41 Million | ▲ +125.8% |
| 2022 | 0.28x | CN¥285.37 Million | CN¥30.82 Million | CN¥1.00 Billion | ▲ +15.8% |
| 2021 | 0.25x | CN¥299.11 Million | CN¥206.27 Million | CN¥1.22 Billion | ▼ -52.9% |
| 2020 | 0.52x | CN¥530.39 Million | CN¥398.46 Million | CN¥1.02 Billion | ▲ +99.1% |
| 2019 | 0.26x | CN¥249.41 Million | CN¥153.95 Million | CN¥951.76 Million | ▼ -11.4% |
| 2018 | 0.30x | CN¥306.76 Million | CN¥133.05 Million | CN¥1.04 Billion | ▲ +177.3% |
| 2017 | 0.11x | CN¥62.05 Million | CN¥-36.91 Million | CN¥581.79 Million | ▼ -78.0% |
| 2016 | 0.49x | CN¥205.51 Million | CN¥108.98 Million | CN¥423.43 Million | ▼ -23.7% |
| 2015 | 0.64x | CN¥276.88 Million | CN¥77.49 Million | CN¥435.44 Million | ▼ -46.3% |
| 2014 | 1.18x | CN¥374.68 Million | CN¥101.77 Million | CN¥316.69 Million | ▲ +22.3% |
| 2013 | 0.97x | CN¥233.06 Million | CN¥85.60 Million | CN¥240.88 Million | ▲ +76.8% |
| 2012 | 0.55x | CN¥161.65 Million | CN¥94.15 Million | CN¥295.31 Million | ▼ -36.6% |
| 2011 | 0.86x | CN¥304.01 Million | CN¥171.70 Million | CN¥352.06 Million | ▲ +51.1% |
| 2010 | 0.57x | CN¥188.27 Million | CN¥27.45 Million | CN¥329.46 Million | ▲ +74.5% |
| 2009 | 0.33x | CN¥138.02 Million | CN¥44.51 Million | CN¥421.50 Million | ▼ -8.1% |
| 2008 | 0.36x | CN¥180.28 Million | CN¥110.77 Million | CN¥505.85 Million | ▼ -53.1% |
| 2007 | 0.76x | CN¥310.67 Million | CN¥78.98 Million | CN¥408.62 Million | ▲ +792.6% |
| 2006 | 0.09x | CN¥33.68 Million | CN¥19.12 Million | CN¥395.40 Million | — |